pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Demographic and clinical characteristics of 8 studies included in the systematic review

Ref.StudyGestational age (weeks)Birth weight (g)Type of delivery, NInitial arterial blood gases valuesMean blood pressure (mmHg)

TheophyllinePlacebopHBase deficit (mEq/L)

TheophyllinePlaceboTheophyllinePlacebo(NVD/CS)(NVD/CS)TheophyllinePlaceboTheophyllinePlaceboTheophyllinePlacebo
20Bakr AF (2005)39.2 ± 1.439.6 ± 1.33320 ± 1903250 ± 2456/148/127.02 ± 0.107.03 ± 0.1217.35 ± 2.3918.27 ± 4.1047 ± 745 ± 6

12Bhat MA et al. (2006)38.2 ± 0.7938.1 ± 0.882770 ± 4002780 ± 23028/1222/87.0 ± 0.097.0 ± 0.04Base excess -18.0 ± 1.8Base excess -17.0 ± 2.0145 ±3.245±2.6

13Eslami Z et al. (2009)------------

21Jenik AG et al. (2000)39.3 ± 1.639.4 ± 1.43256 ± 3093387 ± 37610/1414/137.04 ± 0.137.02 ± 0.17Base excess -18.32 ± 2.45Base excess -19.15 ± 4.0751 ± 849 ± 6

22Khurshid G et al. (2017)38.18 ± 1.1538.45 ± 1.413000 ± 5003000 ± 500--------

14Merrikhi AR et al. (2012)------------

15Raina A et al. (2016)38.56 ± 1.1638.54 ± 1.202900 ± 4002920 ± 39048/3045/36----49 ± 748 ± 6

23Saeidi R et al. (2013)------------

NVD = normal vaginal delivery; CS = cesarean section

Korean J Clin Pharm 2019;29:115-24 https://doi.org/10.24304/kjcp.2019.29.2.115
© 2019 Korean J Clin Pharm